NCT05974488 The Efficacy of Distal Pharyngeal Airway for Oxygenation During TEE
| NCT ID | NCT05974488 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Miami |
| Condition | Airway Obstruction |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2023-11-30 |
| Primary Completion | 2026-10-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2023-11-30 with a primary completion date of 2026-10-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to investigate the effect of using the McMurray Enhanced Airway (MEA) which is a flexible extended-length distal pharyngeal airway on improving oxygen delivery compared to standard nasal cannula.
Eligibility Criteria
Inclusion Criteria: * Age \> or = 18 years old * Patients willing to participate and provide an informed consent * Patients scheduled to undergo an elective TEE procedure. Exclusion Criteria: * Patients with history of uncontrolled gastroesophageal reflux disease * Patients with anatomical airway obstruction * Have any condition that, in the opinion of the investigator, would compromise the well-being of the patient or the study or prevent the patient from meeting or performing study requirements
Contact & Investigator
Fouad G Souki, MD
PRINCIPAL INVESTIGATOR
University of Miami
Frequently Asked Questions
Who can join the NCT05974488 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Airway Obstruction. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05974488 currently recruiting?
Yes, NCT05974488 is actively recruiting participants. Contact the research team at fsouki@med.miami.edu for enrollment information.
Where is the NCT05974488 trial being conducted?
This trial is being conducted at Miami, United States.
Who is sponsoring the NCT05974488 clinical trial?
NCT05974488 is sponsored by University of Miami. The principal investigator is Fouad G Souki, MD at University of Miami. The trial plans to enroll 50 participants.